IL17A and COVID-19: Therefore, this network also displays the contribution of increased pro-inflammatory molecules or signaling pathways (IL1B, IL6, IL8, IL17a) and upregulated chemokine signaling (CXCR4 signaling, CCL5) observed in severe COVID-19 outcomes.